blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2366408

EP2366408 - Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.05.2013
Database last updated on 11.09.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU
published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Laboratorios SALVAT, S.A.
Calle Gall 30-36
08950 Esplugues de Llobregat, Barcelona / ES
[2011/38]
Inventor(s)01 / Ruiz i Pol, Jaume
LABORATORIOS SALVAT, S.A.
Gall, 30-36
E-08950, Esplugues de LLobregat-Barcelona / ES
02 / Izquierdo Torres, Francisca
LABORATORIOS SALVAT, S.A.
Gall, 30-36
E-08950 Esplugues de LLobregat - Barcelona / ES
 [2012/29]
Former [2011/38]01 / Ruizipol, Jaume
LABORATORIOS SALVAT, S.A.
Gall, 30-36
E-08950, Esplugues de LLobregat-Barcelona / ES
02 / Izquierdo Torres, Francisca
LABORATORIOS SALVAT, S.A.
Gall, 30-36
E-08950 Esplugues de LLobregat - Barcelona / ES
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[N/P]
Former [2012/29]ABG Patentes, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
Former [2011/38]ABG Patentes, S.L.
Avenida de Burgos 16D Edificio Euromor
28036 Madrid / ES
Application number, filing date10155005.101.03.2010
[2011/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2366408
Date:21.09.2011
Language:EN
[2011/38]
Type: B1 Patent specification 
No.:EP2366408
Date:18.07.2012
Language:EN
[2012/29]
Search report(s)(Supplementary) European search report - dispatched on:EP29.09.2010
ClassificationIPC:A61K47/10, A61K47/12, A61K47/14, A61K47/32, A61K47/38, A61K9/00, A61K31/58
[2012/04]
CPC:
A61K9/0046 (EP,KR,US); A61K47/32 (KR); A61K31/496 (EP,KR,US);
A61K31/573 (EP,KR,US); A61K31/58 (EP,KR,US); A61K45/06 (EP,KR,US);
A61K47/12 (KR); A61K47/14 (KR); A61K47/38 (KR);
A61K9/08 (EP,KR,US); A61P27/16 (EP); A61P29/00 (EP);
A61P31/04 (EP); A61K2300/00 (KR) (-)
C-Set:
A61K31/496, A61K2300/00 (EP,US);
A61K31/573, A61K2300/00 (US,EP);
A61K31/58, A61K2300/00 (US,EP)
Former IPC [2011/38]A61K47/10, A61K47/12, A61K47/14, A61K47/32, A61K47/38, A61K9/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/38]
TitleGerman:Wässrige klare Lösungen aus Fluocinolon-Acetonid zur Behandlung von Ohrentzündungen[2011/38]
English:Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation[2011/38]
French:Solutions claires aqueuses d'acétonide de fluocinolone pour le traitement de l'inflammation otique[2011/38]
Examination procedure11.10.2011Examination requested  [2011/46]
03.02.2012Communication of intention to grant the patent
01.06.2012Fee for grant paid
01.06.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.02.2012
Opposition(s)19.04.2013No opposition filed within time limit [2013/26]
Fees paidRenewal fee
05.01.2012Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.03.2010
AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
MK18.07.2012
MT18.07.2012
NL18.07.2012
RO18.07.2012
SI18.07.2012
SK18.07.2012
SM18.07.2012
BG18.10.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
IE01.03.2013
LU01.03.2013
MC31.03.2013
[2015/34]
Former [2015/32]AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
MK18.07.2012
MT18.07.2012
NL18.07.2012
RO18.07.2012
SI18.07.2012
SK18.07.2012
SM18.07.2012
BG18.10.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
IE01.03.2013
MC31.03.2013
Former [2015/24]AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
MT18.07.2012
NL18.07.2012
RO18.07.2012
SI18.07.2012
SK18.07.2012
SM18.07.2012
BG18.10.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
IE01.03.2013
MC31.03.2013
Former [2014/32]AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
MT18.07.2012
NL18.07.2012
RO18.07.2012
SI18.07.2012
SK18.07.2012
BG18.10.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
IE01.03.2013
MC31.03.2013
Former [2014/07]AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
NL18.07.2012
RO18.07.2012
SI18.07.2012
SK18.07.2012
BG18.10.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
IE01.03.2013
MC31.03.2013
Former [2013/47]AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
NL18.07.2012
RO18.07.2012
SI18.07.2012
SK18.07.2012
BG18.10.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
MC31.03.2013
Former [2013/34]AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
NL18.07.2012
RO18.07.2012
SI18.07.2012
SK18.07.2012
BG18.10.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
Former [2013/23]AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
NL18.07.2012
RO18.07.2012
SI18.07.2012
SK18.07.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
Former [2013/22]AT18.07.2012
BE18.07.2012
CY18.07.2012
CZ18.07.2012
EE18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
NL18.07.2012
SI18.07.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
Former [2013/15]AT18.07.2012
BE18.07.2012
CY18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
NL18.07.2012
SI18.07.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
Former [2013/13]AT18.07.2012
BE18.07.2012
CY18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
SI18.07.2012
GR19.10.2012
IS18.11.2012
PT19.11.2012
Former [2013/11]AT18.07.2012
BE18.07.2012
CY18.07.2012
HR18.07.2012
LT18.07.2012
LV18.07.2012
SI18.07.2012
GR19.10.2012
IS18.11.2012
Former [2013/10]AT18.07.2012
BE18.07.2012
CY18.07.2012
HR18.07.2012
LT18.07.2012
IS18.11.2012
Former [2013/08]AT18.07.2012
BE18.07.2012
LT18.07.2012
Former [2013/07]AT18.07.2012
Documents cited:Search[A]GB1013180  (ICI LTD) [A] 1-15 * page 1, column r, line 78 - page 2, column l, line 15 * * examples 1,2; claim - *;
 [A]GB1133800  (ICI LTD) [A] 1-15 * page 1, column l, lines 22-31 * * page 1, column r, lines 51-56 *;
 [Y]GB1411432  (MEDISAN AB) [Y] 1-15 * the whole document *;
 [Y]DE2515594  (WARNER LAMBERT CO) [Y] 1-15 * example 2 *;
 [AD]EP0995435  (SENJU PHARMA CO [JP]) [AD] 1-15* the whole document *;
 [Y]US2009325938  (LICHTER JAY [US], et al) [Y] 1-15 * paragraphs [0007] , [0013] * * paragraphs [0174] , [0179]; example 10; claim - *;
 [Y]US2010036000  (LICHTER JAY [US], et al) [Y] 1-15 * paragraphs [0243] , [ 252] - [0254] * * example -; claim - *
by applicantEP1312356
 US2009111780
    - T.L. LEMKE; D.A. WILLIAMS, Foye's Principles of Medicinal Chemistry, WOLTERS KLUWER, (2007), page 902
    - J. COLOE; M.J. ZIRWAS, "Allergens in corticosteroid vehicles", DERMATITIS, (2008), vol. 19, no. 1, pages 38 - 42
    - P.D. DARBRE; P.W. HARVEY, "Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks", J APPL TOXICOL., (2008), vol. 28, no. 5, pages 561 - 578
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.